Ecolab stock target cut to $243 by Berenberg on cost concerns

Published 01/05/2025, 11:04
Ecolab stock target cut to $243 by Berenberg on cost concerns

On Thursday, Berenberg adjusted its price target for Ecolab Inc . (NYSE:ECL) shares, reducing it to $243 from the previous $252, while retaining a Hold rating on the stock. Currently trading at $251.43, InvestingPro analysis indicates the stock appears overvalued at these levels. The firm’s decision followed Ecolab’s first-quarter earnings report for 2025, which was released on April 29 and met consensus expectations. Additionally, the company reaffirmed its full-year earnings per share (EPS) guidance, projecting it to be between $7.42 and $7.62, closely aligned with analysts’ consensus forecast of $7.51 for FY2025.

The price target revision by Berenberg reflects a slight 1% decrease in their full-year 2025 EPS estimate, now set at $7.49. This adjustment was attributed to a combination of factors impacting Ecolab’s financials. Higher revenues were noted, stemming from newly introduced price surcharges and favorable foreign exchange rates. Despite these challenges, InvestingPro data shows the company maintains excellent financial health with an overall score of "GREAT," supported by its impressive track record of raising dividends for 39 consecutive years. However, these benefits were reportedly outweighed by increased costs due to tariffs and a deceleration in volume growth.

Ecolab recently announced the implementation of a 5% surcharge on its products sold within the United States. This move is intended to counterbalance the rising raw material costs that have been exacerbated by tariffs. Berenberg suggests that the surcharges not only demonstrate Ecolab’s ability to manage costs in challenging economic conditions but also reflect the company’s pricing power and resilience during economic downturns.

The firm’s maintained Hold rating indicates a neutral stance on Ecolab’s stock, suggesting that the analysts see the company as fairly valued at its current market price, given the mix of positive and negative factors influencing its performance. The revised price target of $243 falls within the broader analyst range of $230 to $310, with a consensus recommendation of 2.22 (Hold). For deeper insights into Ecolab’s valuation and growth prospects, investors can access comprehensive analysis and 10+ additional ProTips through InvestingPro’s detailed research reports.

In other recent news, Ecolab Inc. reported its first-quarter earnings for 2025, meeting analyst expectations with an earnings per share (EPS) of $1.5. However, the company’s revenue slightly missed forecasts, coming in at $3.7 billion against the expected $3.71 billion. Despite this, Ecolab experienced a 12% growth in EPS and a 3% increase in organic sales, with notable performance in the Life Sciences and Biopharma segments. Stifel analysts have recently adjusted their outlook on Ecolab, maintaining a Buy rating but reducing the price target from $307 to $303. The firm anticipates Ecolab will meet its 2025 EPS goals through strategic pricing and favorable foreign exchange conditions, despite lower sales volumes. Ecolab’s digital segment also posted a 12% growth, reaching $320 million in annualized revenue. Additionally, the company repurchased $140 million in shares during the first quarter. These developments reflect Ecolab’s ongoing efforts to leverage its strategic initiatives and growth engines to enhance operational efficiency and market share.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.